Replies to post #385764 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

I'm surprised people don't know that Elite failed their Generic Concerta BE study a few years ago.

In the CC either 2 or 3 years ago, I think it was a February CC, Nasrat said the CNS product that we got from SunGen(now Praxgen) was in a BE study and the results were expected in a few months.

They never came.....

They've been working on getting Generic Concerta approved since 2019 or 2020 when Elite fully took back the product from SunGen(now Praxgen).

They can't figure it out.

I would assume Generic Vyvanse is just if not more complicated to development.

We know the BE study that was just completed last week was one of these two products.

Can you recall a BE that Nasrat talked about that didn't come to fruition?